A white bathroom scale with a yellow measuring tape draped over it on a light gray surface.

A Smarter Approach to Weight Support

GLP-1 treatment that works alongside your training, nutrition, and recovery for sustainable results.

A woman with long brown hair smiles and looks happy on the beach at sunset, with the ocean and waves in the background.

Support Your Metabolism, Sustain Your Results

Weight Loss Support with Semaglutide, Tirzepatide, and Retatrutide

There's a reason everyone is talking about the newest once weekly injectables, Semaglutide and Tirzepatide. BeWell is pleased to offer all three of these amazingly effective weight loss options, and explain how they differ. Combined with a nutrient dense diet, exercise, and proper stress management they can be incredible game changers.

Semaglutide

Semaglutide is the evolution of Metformin, one of the first generation options for diabetes that was observed to also promote weight loss in people that took it. Metformin, while a good cost effective oral option, has mitochondrial side effects that can decrease energy reserves with longer term use. Semaglutide came on the scene in 2017 and is approved to lower blood sugar in Type 2 diabetics, and side effects can include significant weight loss in people who have been unable to lose weight with other interventions. It has become very loved by the millions of worldwide users, for the simple reason that they have achieved weight goals when nothing else worked. Side effects of reflux and loose stool with Semaglutide are managed at the right dose, and BeWell encourages smaller individualized dosing to keep these side effects minimal.

Tirzepatide

As much as we love Semaglutide, we might love Tirzepatide even more. Tirzepatide is the evolution of Semaglutide, and has all of the benefits of Semaglutide with an extra action to regulate appetite even further through an additional receptor called GIP. Tirzepatide seems to have fewer side effects than Semaglutide, and many people notice nothing except a greater sense of well-being while on the injections. Tirzepatide costs slightly more than Semaglutide, but many people do not need to go as high on the dosing, which can ultimately render it less expensive than Semaglutide.

Retatrutide

Introducing the newest revolutionary triple action weight loss peptide! Retatrutide not only offers the benefits of Tirzepatide but also helps balance glucagon levels. This groundbreaking solution is set to transform weight loss, diabetes management, insulin resistance, metabolic syndrome, and fatty liver treatment. Clinical trials have shown impressive results with participants achieving a remarkable 7-24% reduction in total body weight over a span of 6-12 months.

Frequently Asked Questions

  • Research has shown that adults taking semaglutide lost an average of almost 15% of their initial body weight. In total, adults on semaglutide treatment lost an average 33.7 lb (15.3 kg) by week 68. However, the weight loss can vary among individuals.

  • Semaglutide injection is used along with diet and exercise to improve blood sugar (glucose) levels in adults with type 2 diabetes. It’s also approved to lower the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes with known heart disease. Additionally, it has been found to promote significant weight loss in individuals who have struggled with other interventions.

  • No, tirzepatide and Ozempic (semaglutide) are not the same. Both are injectable medications used in the treatment of type 2 diabetes and obesity, but they have different mechanisms of action. Tirzepatide acts on both GIP and GLP-1 receptors, while Ozempic acts only on GLP-1 receptors. However, both drugs are effective treatments for type 2 diabetes and have been associated with significant weight loss.